In AML, the reason behind MEIS2 acts as an oncogene is that MEIS2 can directly bind to the Runt domain of AML1‐ETO to impair repressive DNA binding of AML1‐ETO, resulting in the upregulation of proto‐oncogene YES1.19 Here, YES1 is linked to acute myeloid leukemia.